ARROWHEAD PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q2 2024.
  • Arrowhead Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 124M shares, a 16.1% increase year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 107M shares, a 1.26% increase from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 105M shares, a 1.62% increase from 2021.
  • Arrowhead Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 104M shares, a 3% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 124M +17.2M +16.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 123M +16.5M +15.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 107M +1.38M +1.3% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-06
Q3 2023 107M +1.32M +1.26% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-29
Q2 2023 107M +1.25M +1.18% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 107M +1.21M +1.15% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 106M +1.51M +1.44% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-06
Q3 2022 105M +1.68M +1.62% Jul 1, 2022 Sep 30, 2022 10-K 2023-11-29
Q2 2022 106M +1.65M +1.59% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 106M +1.68M +1.62% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 105M +1.78M +1.73% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-06
Q3 2021 104M +3.02M +3% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-29
Q2 2021 104M +2.26M +2.22% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 104M +2.21M +2.18% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 103M +5.67M +5.84% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-02
Q3 2020 101M +6.86M +7.31% Jul 1, 2020 Sep 30, 2020 10-K 2022-11-28
Q2 2020 102M +6.91M +7.28% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 102M +7.5M +7.96% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 97.1M +6M +6.59% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 93.9M +10.2M +12.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-22
Q2 2019 94.9M +7.3M +8.33% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 94.2M +10.1M +12% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 91.1M +16.3M +21.7% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-05
Q3 2018 83.6M Jul 1, 2018 Sep 30, 2018 10-K 2020-11-23
Q2 2018 87.6M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 84.1M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 74.8M Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q2 2012 11.2M +4.06M +56.5% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-13
Q1 2012 10.7M +3.48M +48.5% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-08
Q2 2011 7.18M -57.4M -88.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 7.18M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q2 2010 64.6M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.